Dynegy Inc. (NYSE:DYN) has closed the sale of an additional 1,500,000
shares of its common stock pursuant to the exercise by the underwriters
of their option to purchase additional shares in connection with the
company’s previously announced public offering, which was completed on
October 14, 2014.
Inc. (NYSE: RLD), a leading global visual technology company, said
today that it has identified $16 million in additional cost savings as
it continues its efforts to streamline its organization and introduce
additional efficiencies to its cost structure.
Nevsun Announces Additional Positive Exploration Drilling Results for Harena Canada NewsWire
HIGHLIGHTS Intersections of massive sulphide including: Hole HX-021: 1.82% Cu, 2.66% Zn, 0.40 g/t Au, 40.6 g/t Ag over 36.8 meters Hole HX-022: 2.66% Cu, 0.96% Zn, 0.79 g/t Au, 44.8 g/t Ag over 9.9 meters Hole HX-023: 1.04% Cu, 3.82% Zn, 1.05 g/t Au, 28.5 g/t Ag over 38.0 meters High grade gold-rich footwall stringer intersections including: Hole HX-025: 0.37% Cu, 1.72% Zn, 3.13 g/t Au, 85.5 g/t Ag over 17.9 meters Deposit now extended 350 meters down plunge from original resource to a depth of 400 meters Mineralization remains open with good widths still being encountered Additional drilling and geophysical surveys ongoing VANCOUVER , Nov.
Bellatrix Announces the Sale of Minority Interests in its New Deep Cut Gas Plant and Facilities Being Constructed in the Alder Flats Area and the Securing of Additional Strategic Firm Capacity in the Strachan Area Canada NewsWire
TSX, NYSE: BXE CALGARY , Dec.
Sign-up for Bellatrix Announces the Sale of Minority Interests in its New Deep Cut Gas Plant and Facilities Being Constructed in the Alder Flats Area and the Securing of Additional Strategic Firm Capacity in the Strachan Area investment picks
CyberArk Software Ltd., a global leader and pioneer of a new layer of IT
security solutions that protects organizations from cyber attacks that
have made their way inside the network perimeter, announced the closing
of its initial public offering of 6,164,000 ordinary shares at a price
to the public of $16.00 per share, which includes 804,000 ordinary
shares purchased pursuant to the full exercise of the underwriters’
option to purchase additional shares.
Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical
company focused on developing and commercializing first-in-class, oral
low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies
for the treatment of hypercholesterolemia and other cardiometabolic risk
markers, today announced the closing of its follow-on public offering of
4,887,500 shares of common stock, offered at a price to the public of
$20.00 per share, which includes the exercise in full by the
underwriters of their option to purchase 637,500 additional shares of
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.